CRN’s “Suggested Elements for a Voluntary Label for Kava Products” stem from a thorough process of scientific assessment, consultation and coordination with the FDA, other trade associations, and external scientific advisors. It is important for CRN members to recognize that neither the FDA, CRN, nor any other evaluation has concluded that scientific evidence establishes a causal link between kava consumption and liver issues. Therefore, CRN’s recommendation is seen solely as a matter of ample prudence.
Here’s what CRN recommends for kava labels:
Consumer Safety Information:
The label should advise that the FDA has noted a rare, but severe, risk of liver injury potentially associated with kava-containing dietary supplements. Clear warnings help consumers make informed choices, especially those with specific health conditions.
Consulting a Healthcare Professional:
Consumers should be encouraged to speak with a healthcare provider before using kava if they have or have had liver problems, frequently consume alcohol, or take medications. Proactive consultation can help identify potential risks.
Symptoms to Watch For:
Labels should include guidance to stop use and consult a doctor if symptoms of liver problems arise, such as jaundice, brown urine, nausea, vomiting, or unusual fatigue. Early identification of potential issues is critical.
Usage Restrictions:
- Not suitable for individuals under 18 or for pregnant or breastfeeding women.
- Avoid combining kava with alcoholic beverages or excessive use that may impair activities like driving or operating machinery.
CRN member companies go beyond basic requirements, choosing to self-regulate to uphold your trust. This guideline is just one example of their commitment to maintaining the highest standards of ethics and integrity in the products you depend on every day.
When you choose products from CRN member companies, you can trust in the brand’s commitment to your well-being and safety.